ISSN: 2572-4118

Breast Cancer: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Breast Can Curr Res 2022, Vol 7(3): 164
  • DOI: 10.4172/2572-4118.1000164

Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells

Jianfang Cao*
Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
*Corresponding Author : Jianfang Cao, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA, Email: jianfangc@gmail.com

Received Date: May 27, 2022 / Accepted Date: Jun 23, 2022 / Published Date: Jun 24, 2022

Abstract

Movement of 78-kDa glucose-controlled protein from endoplasmic reticulum to plasma film addresses a change in outlook past its conventional capability as an ER chaperone protein. Cell surface GRP78 applies novel flagging capabilities, and instruments basic its cell surface articulation are simply arising. Obtained tamoxifen obstruction of bosom malignant growth cells is went with raised degree of csGRP78. Subsequently, the tamoxifen-safe MCF7 bosom malignant growth cells addresses a clinically pertinent model to concentrate on components of csGRP78 articulation.

Citation: Cao J (2022) Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells. Breast Can Curr Res 7: 164. Doi: 10.4172/2572-4118.1000164

Copyright: © 2022 Cao J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top